Novo Nordisk A/S
NVO
$47.26
$1.292.81%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -19.36% | 20.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.36% | 20.52% | |||
| Cost of Revenue | 25.10% | -5.46% | |||
| Gross Profit | -26.62% | 26.19% | |||
| SG&A Expenses | 22.73% | -24.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 119.60% | 228.92% | |||
| Total Operating Expenses | 20.58% | -16.52% | |||
| Operating Income | -44.29% | 66.66% | |||
| Income Before Tax | -57.00% | 79.17% | |||
| Income Tax Expenses | -56.99% | 83.89% | |||
| Earnings from Continuing Operations | -57.00% | 77.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.00% | 77.89% | |||
| EBIT | -44.29% | 66.66% | |||
| EBITDA | -41.71% | 69.67% | |||
| EPS Basic | -56.86% | 77.94% | |||
| Normalized Basic EPS | -46.70% | 62.85% | |||
| EPS Diluted | -56.86% | 77.85% | |||
| Normalized Diluted EPS | -46.72% | 62.85% | |||
| Average Basic Shares Outstanding | -0.33% | -0.02% | |||
| Average Diluted Shares Outstanding | -0.29% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||